JOHN C MARTIN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN C MARTIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN C MARTIN. JOHN C MARTIN is a Chairman and CEO in GILEAD SCIENCES INC ($GILD) and a Director in GILEAD SCIENCES INC ($GILD) and an Executive Chairman in GILEAD SCIENCES INC ($GILD) and a President and CEO in GILEAD SCIENCES INC ($GILD) and a Director in Sarepta Therapeutics, Inc. ($SRPT) and a Director in Kronos Bio, Inc. ($KRON).
Address: 333 LAKESIDE DRIVE FOSTER CITY 94404 CA
Companies in which JOHN C MARTIN is an Insider
GILEAD SCIENCES INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN C MARTIN: Director, Executive Chairman, Chairman and CEO, President and CEO
Holdings: 2,885,507 shares
Current Value: $211,017,127
Latest Transaction: Feb 08 2019
$GILD Market Capitalization: $88.05B
$GILD Previous Close: $73.13
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kronos Bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN C MARTIN: Director
Holdings: 914,333 shares
Latest Transaction: Oct 16 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sarepta Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN C MARTIN: Director
Holdings: 7,913 shares
Current Value: $230,822
Latest Transaction: Mar 05 2021
$SRPT Market Capitalization: $1.60B
$SRPT Previous Close: $29.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JOHN C MARTIN
Sentiment: All, GILD, KRON, SRPT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 05 2021 | SRPT | Sarepta Therapeuti ... | MARTIN JOHN C | Director | Option Exercise | A | 87.11 | 5,518 | 480,673 | 5,518 | |
| Mar 05 2021 | SRPT | Sarepta Therapeuti ... | MARTIN JOHN C | Director | Grant | A | 0.00 | 2,726 | 0 | 7,913 | 5.2 K to 7.9 K (+52.55 %) |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | MARTIN JOHN C | Director | Option Exercise | C | 0.00 | 717,509 | 0 | 0 | |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | MARTIN JOHN C | Director | Option Exercise | C | 0.00 | 866,667 | 0 | 0 | |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | MARTIN JOHN C | Director | Buy | P | 19.00 | 75,800 | 1,440,200 | 1,952,364 | 1.9 M to 2 M (+4.04 %) |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | MARTIN JOHN C | Director | Option Exercise | C | 0.00 | 717,509 | 0 | 0 | |
| Oct 16 2020 | KRON | Kronos Bio, Inc. | MARTIN JOHN C | Director | Buy | C | 16.15 | 205,260 | 3,314,949 | 1,876,564 | 1.7 M to 1.9 M (+12.28 %) |